List of insiders holdings for TELA Bio Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | EW HEALTHCARE PARTNERS FUND 2 L.P. EW HEALTHCARE PARTNERS FUND 2-A L.P. EW Healthcare Partners Fund 2 GP L.P. EW Healthcare Partners Fund 2-UGP LLC See Remarks 10% Owner | 2025-11-17 16:26:40 | 7,714,709 0 | 7,714,709 | Form 13G |
| 2 | Opaleye Management Inc. Former 10% Owner. | 2023-04-20 16:05:29 | 0 2,072,813 | 2,072,813 | Form 4 |
| 3 | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner | 2024-10-25 16:24:30 | 1,182,717 0 | 1,182,717 | Form 13D |
| 4 | Ellis Ronald J. Jr. Pacira BioSciences Inc. Director 10% Owner | 2019-11-13 21:06:16 | 0 774,056 | 774,056 | Form 4 |
| 5 | Friedman Ashley Director | 2019-11-13 20:48:59 | 0 684,948 | 684,948 | Form 4 |
| 6 | Zuga Matt Director | 2019-11-13 20:57:28 | 0 623,924 | 623,924 | Form 4 |
| 7 | KOBLISH ANTONY Chief Executive Officer | 2025-04-02 16:45:22 | 590,110 0 | 590,110 | Form 4 |
| 8 | RTW INVESTMENTS LP WONG RODERICK 10% Owner | 2023-02-14 10:10:15 | 390,364 0 | 390,364 | Form 13G |
| 9 | Cuca Roberto COO and CFO | 2025-02-25 16:58:19 | 292,033 0 | 292,033 | Form 4 |
| 10 | Blizard Jeffrey President | 2025-06-02 16:59:08 | 273,225 0 | 273,225 | Form 4 |
| 11 | Talmo Paul Chief Technology Officer | 2025-04-02 16:49:36 | 123,882 0 | 123,882 | Form 4 |
| 12 | PERSENAIRE MAARTEN Chief Medical Officer | 2021-02-26 17:27:45 | 112,687 0 | 112,687 | Form 4 |
| 13 | Firestone Gregory A. Chief Commercial Officer | 2025-08-05 16:08:04 | 106,790 0 | 106,790 | Form 4 |
| 14 | Murphy Peter C. Chief Commercial Officer | 2024-04-02 19:42:50 | 48,129 0 | 48,129 | Form 4 |
| 15 | Smeykal Megan Chief Accounting Officer | 2025-04-02 16:46:56 | 36,831 0 | 36,831 | Form 4 |
| 16 | Burgess Vincent J Director | 2025-05-30 16:15:24 | 35,030 0 | 35,030 | Form 4 |
| 17 | COLLERAN LISA N Director | 2025-05-30 16:14:50 | 30,170 0 | 30,170 | Form 4 |
| 18 | Azarbarzin Kurt Director | 2025-05-30 16:17:55 | 30,170 0 | 30,170 | Form 4 |
| 19 | O'Brien Federica F. Director | 2025-05-30 16:18:27 | 30,170 0 | 30,170 | Form 4 |
| 20 | EVANS DOUGLAS G Director | 2025-05-30 16:18:35 | 30,170 0 | 30,170 | Form 4 |
| 21 | Rocchio Betty Jo Director | 2025-10-10 16:07:44 | 29,475 0 | 29,475 | Form 4 |
| 22 | Plovanic William J. Director | 2025-11-03 16:22:34 | 29,475 0 | 29,475 | Form 4 |
| 23 | Greenhalgh Ellis Skott Chief Technology Officer | 2022-02-28 16:24:06 | 27,826 0 | 27,826 | Form 4 |
| 24 | Quaker BioVentures II LP Quaker BioVentures Capital II L.P. 10% Owner | 2022-06-23 06:31:45 | 18,096 0 | 18,096 | Form 13G |
| 25 | Brennan Nora Chief Financial Officer | 2021-04-02 14:41:14 | 17,696 0 | 17,696 | Form 4 |
| 26 | Nosenzo John Director | 2023-06-02 16:36:54 | 11,630 0 | 11,630 | Form 4 |
| 27 | Oliva Adele C Director | 2020-06-08 16:38:42 | 8,806 0 | 8,806 | Form 4 |